Search Login Register
Aicardi Syndrome
Summary
Description:
A rare genetic disorder characterized by partial or complete absence of the CORPUS CALLOSUM, resulting in infantile spasms, MENTAL RETARDATION, and lesions of the RETINA or OPTIC NERVE.
Also Known As:
Agenesis of Corpus Callosum; Aicardi's Syndrome; Callosum Ageneses, Corpus; Callosum Agenesis, Corpus; Corpus Callosum Ageneses Show All >>
Networked: 82
relevant articles (2 outcomes,
2 trials/studies)
for this Disease
Key Drugs and Agents for Aicardi Syndrome
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Vigabatrin
:
1 outcome in 2 results
:
FDA 2
-
Adrenocorticotropic Hormone (ACTH)
:
1 outcome in 2 results
:
FDA 7
-
DNA (Deoxyribonucleic Acid)
:
1 study in 3 results
: IBA
-
Fluorescein (Funduscein)
:
1 study in 1 result
:
FDA 3
Generic
-
XXY syndrome
:
9 results
: IBA
-
Retinaldehyde (Retinal)
:
7 results
: IBA
-
X-linked Hydrocephalus
:
4 results
: IBA
-
Colpocephaly
:
4 results
: IBA
-
Shapiro syndrome
:
3 results
: IBA
-
Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)
:
2 results
: IBA
Show All >>
Diseases Related to Aicardi Syndrome
-
Seizures (Seizure)
-
Lissencephaly
-
Mental Retardation (Idiocy)
-
Hydrocephalus (Hydrocephaly)
-
Macrocephaly
Show All >>
Key Therapies for Aicardi Syndrome
Efficacy Chart >>
-
Vagus Nerve Stimulation
:
1 result
-
Split-Brain Procedure (Split-Brain)
:
1 result
-
Fundoplication
:
1 result
-
Ventriculoperitoneal Shunt
:
1 result
-
Traction
:
1 result
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.